2026 ICD-10-CM Diagnosis Code E72.548Other secondary hyperoxaluria
E72.548 is a billable ICD-10-CM diagnosis code for other secondary hyperoxaluria. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 695 through 696. Coders also document this condition as antifreeze oxalosis.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Antifreeze oxalosis
- Secondary oxalosis
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Disorder (of) - See Also: Disease;
- hyperoxaluria - R82.992
- specified type NEC - E72.548
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Disorder(of)
- glycine metabolism
- hyperoxaluria
- secondary
- specified type NEC
Code History & ChangesHistory
New Code E72.548 was added to the ICD-10-CM code set for FY 2026, effective October 1, 2025.
Replacement E72.548 replaces the following previously assigned code(s):
- R82.992 - Hyperoxaluria
Questions About E72.548Overview
Is E72.548 (Secondary hyperoxaluria) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report other secondary hyperoxaluria on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does E72.548 group to?
When other secondary hyperoxaluria is the principal diagnosis on an inpatient stay, it groups to MS-DRG 695, 696, with relative weights from 0.6890 to 1.1438 depending on complications. Higher weights mean higher Medicare reimbursement.
